PHRM 825: Antiadrenergic Drugs Flashcards
1
Q
Phenoxybenzamine
A
- Non-selective alpha receptor antagonist (a1 and a2)
- Also blocks Ach, Histamine, and serotonin receptors
- Irreversible antagonist resulting from covalent modification of receptor
2
Q
Phentolamine
A
- Non-selective alpha receptor antagonist (a1 and a2)
- Competitive (reversible) blocker
- Potent vasodilator, but induces pronounced reflex tachycardia
- Blocks of presynaptic alpha 2 receptors may promote release of NE
- Also blocks 5-HT receptors, and is a muscarinic and histamine receptor agonist
3
Q
Prazosin
A
- alpha 1 adrenergic receptor antagonist
- Half-life: 3 hours
- “Quinazoline”
- Undergo extensive metabolism, excreted mainly in the bile
- Vasodilators
- Relaxation of smooth muscle in enlarged prostate and in bladder base
- “First-dose” effect
4
Q
Terazosin
A
- alpha 1 adrenergic receptor antagonist
- Half-life: 12 hours
- “Quinazoline”
- Undergo extensive metabolism, excreted mainly in the bile
- Vasodilators
- Relaxation of smooth muscle in enlarged prostate and in bladder base
- “First-dose” effect
5
Q
Doxazosin
A
- alpha 1 adrenergic receptor antagonist
- Half-life: 20 hours
- “Quinazoline”
- Undergo extensive metabolism, excreted mainly in the bile
- Vasodilators
- Relaxation of smooth muscle in enlarged prostate and in bladder base
- “First-dose” effect
6
Q
Yohimbine
A
- alpha 2 adrenergic receptor antagonist
- Indole alkaloid
- Found in Rubaceae and related trees. Also in Rauwolfia Serpentina
- Blockade of alpha 2 receptor increases sympathetic discharge
- Folklore suggests use in the treatment of male impotence
7
Q
Propranolol
A
- Non-selective beta-adrenergic receptor antagonist
- Lipophilic
- Local anesthetic properties
- Blockade is activity-dependent
8
Q
Pharmacologic effects of all beta-adrenergic receptor antagonists
A
- Decreased cardiac output
- Reduced renin release
- Increase VLDL, decrease HDL
- Inhibit lipolysis
- Inhibit compensatory glycogenolysis and glucose release in response to hypoglycemia
- Increase bronchial airway resistance
9
Q
What are therapeutic uses for beta-adrenergic receptor antagonists?
A
- Hypertension
- Angina
- Cardiac arrhythmias
- Migraine
- Stage fright
- Thyrotoxicosis
- Glaucoma
- Congestive heart failure (types II and III)
10
Q
Nadolol
A
- Non-selective beta-adrenergic receptor antagonists
- Less lipophilic than propranolol
- Long half-life: ~20 hours
- Mostly excreted unchanged in urine (not metabolized)
- Administration: Oral
- Uses: Hypertension, angina, migraine
11
Q
Timolol
A
- Non-selective beta-adrenergic receptor antagonist
- Thiadiazole nucleus with morpholine ring
- Administration: Oral, ophthalmic
- Uses: Hypertension, angina, migraine, glaucoma
12
Q
How do beta blockers affect pupil size?
A
They don’t. There are no beta receptors in the eye
13
Q
Pindolol
A
- Non-selective beta-adrenergic receptor antagonist
- Possesses “intrinsic sympathomimetic activity” (ISA)
- Partial agonist
- Less likely to cause bradycardia and lipid abnormalities
- Administration: Oral
- Uses: Hypertension, angina, migraine
14
Q
Carteolol
A
- Non-selective beta-adrenergic receptor antagonist
- Possess “intrinsic sympathomimetic activity” (ISA)
- Partial agonist
- Less likely to cause bradycardia and lipid abnormalities
- Administration: Oral, Ophthalmic
- Uses: Hypertension, glaucoma
15
Q
Metoprolol
A
- Selective beta 1-adrenergic receptor antagonist
- “Cardio-selective”
- Less bronchoconstriction
- Moderate lipophilicity
- Half-life: 3-4 hours
- Significant first-pass metabolism
- Administration: Oral, parenteral
- Uses: Hypertension, angina, antiarrhythmic, congestive heart failure
16
Q
Atenolol
A
- Selective beta 1-adrenergic receptor antagonist
- “Cardio-selective”
- Less bronchoconstriction
- Low lipophilicity
- Half-life 6-9 hours
- Administration: Oral, parenteral
- Uses: Hypertension, angina
17
Q
Bisopropolol
A
- Selective beta 1-adrenergic receptor antagonist
- “Cardio-selective”
- Less bronchoconstriction
- Moderate lipophilicity
- Half-life: 3-4 hours
- Significant first-pass metabolism
- Administration: Oral, parenteral
- Uses: Hypertension, angina, antiarrhythmic, congestive heart failure
18
Q
Esmolol
A
- Selective beta 1-adrenergic receptor antagonist
- Very short acting
- Half-life: 9 minutes
- Rapid hydrolysis by esterases found in RBCs
- Administration: Parenteral
- Incompatible with sodium bicarbonate
- Uses: Supraventricular tachycardia, atrial fibrillation/flutter, perioperative hypertension
19
Q
Nebivolol
A
- 3rd generation beta 1-adrenergic receptor antagonist
- Low lipid solubility
- Vasodilation due to nitric oxide production
- Hypertension
20
Q
Labetolol
A
- Non-selective beta receptor antagonist
- Alpha 1 receptor antagonist
- Two asymmetric carbons
- (1R, 1’R)-isomer possessing beta blocking activity
- (1S, 1’R)-isomer possessing alpha 1 receptor blocking activity
- Beta blocking activity prevents reflex tachycardia normally associated with alpha 1 receptor antagonists
- Administration: oral, parenteral
- Uses: Hypertension, hypertensive crisis
21
Q
Carvedilol
A
- Non-selective beta receptor antagonist
- Alpha 1 receptor antagonist
- Both enantiomers antagonize alpha 1 receptors
- Only (S)-enantiomer possesses beta-blocking activity
- Beta-blocking activity prevents reflex tachycardia normally associated with alpha receptor antagonists
- Administration: Oral
- Uses: Hypertension, congestive heart failure (types II and III)
22
Q
Side effects of beta-blocker:
A
- Bradycardia
- AV block
- Sedation
- Mask symptoms of hypoglycemia
- Withdrawal synrome
23
Q
Contraindications of beta blockers
A
- Asthma
- COPD
- Congestive heart failure (Type IV)
24
Q
Reserpine
A
- Catecholamine depleter
- Indole alkaloid obtained from the root of Rauwolfia serpentina
- Block vesicular monamine transporters
- Deplete vesicular pool of NE
- Slow onset of action
- Sustained effect (weeks)
- Used in the treatment of hypertension
- May precipitate depression
25
Q
Bretylium tosylate
A
- Reduces storage or release of NE
- Aromatic quaternary ammonium
- Precise mechanism unknown
- Displace and release NE and prevent further release (depletion)
- Local anesthetic
- Administered: Parenteral
- Uses: Antiarrhythmic (ventricular fibrillation)